Tag Archives: type-publication

Hypoxia-Sensing CAR T Cells Provide Safety and Efficacy in Treating Solid Tumors

Using murine xenograft models, scientists demonstrated that, despite widespread expression of ErbB receptors in healthy organs, the approach provided anti-tumor efficacy without off-tumor toxicity.
[Cell Reports Medicine]
Kosti, P., Opzoomer, J. W., Larios-Martinez, K. I., Henley-Smith, R., Scudamore, C. L., Okesola, M., Taher, M. Y. M., Davies, D. M., Muliaditan, T., Larcombe-Young, D., Woodman, N., Gillett, C. E., Thavaraj, S., Maher, J., & Arnold, J. N. (2021). Hypoxia-sensing CAR T cells provide safety and efficacy in treating solid tumors. Cell Reports Medicine, 0(0). https://doi.org/10.1016/j.xcrm.2021.100227 Cite
Full ArticleGraphical Abstract
Bookmark

No account yet? Register

0
Share

Genetic In Vivo Engineering of Human T Lymphocytes in Mouse Models

Scientists describe how to humanize immunodeficient mice with hematopoietic stem cells and precondition and administer the vector stocks.
[Nature Protocols]
Weidner, T., Agarwal, S., Perian, S., Fusil, F., Braun, G., Hartmann, J., Verhoeyen, E., & Buchholz, C. J. (2021). Genetic in vivo engineering of human T lymphocytes in mouse models. Nature Protocols, 1–31. https://doi.org/10.1038/s41596-021-00510-8 Cite
Abstract
Bookmark

No account yet? Register

0
Share

Risk Factors and Outcomes of Diffuse Alveolar Haemorrhage after Allogeneic Hematopoietic Stem Cell Transplantation

Investigators explored the occurrence and prognosis of diffuse alveolar haemorrhage after allogeneic hematopoietic stem cell transplantation.
[Bone Marrow Transplantation]
Wu, J., Fu, H.-X., He, Y., Mo, X.-D., Liu, X., Cai, X., Gui, R.-Y., Liu, H.-X., Yan, C.-H., Chen, Y.-H., Chang, Y.-J., Xu, L.-P., Liu, K.-Y., Huang, X.-J., & Zhang, X.-H. (2021). Risk factors and outcomes of diffuse alveolar haemorrhage after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplantation, 1–11. https://doi.org/10.1038/s41409-021-01293-y Cite
Full Article
Bookmark

No account yet? Register

0
Share

Frequent Loss-of-Heterozygosity in CRISPR-Cas9–Edited Early Human Embryos

Scientists developed computational pipelines to assess single-cell genomics and transcriptomics datasets from OCT4 CRISPR-Cas9–targeted and control human preimplantation embryos
[Proceedings of the National Academy of Sciences of the United States of America]
Alanis-Lobato, G., Zohren, J., McCarthy, A., Fogarty, N. M. E., Kubikova, N., Hardman, E., Greco, M., Wells, D., Turner, J. M. A., & Niakan, K. K. (2021). Frequent loss-of-heterozygosity in CRISPR-Cas9–edited early human embryos. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2004832117 Cite
Full ArticlePress Release
Bookmark

No account yet? Register

0
Share

A Novel Full-Human CD22-CAR T Cell Therapy with Potent Activity against CD22low B-ALL

Researchers aimed to develop a new CD22-CAR construct with low immunogenicity and potent activity for treating B acute lymphoblastic leukemia (B-ALL) patients who failed from prior CD22-CAR T cell therapies.
[Blood Cancer Journal]
Tan, Y., Cai, H., Li, C., Deng, B., Song, W., Ling, Z., Hu, G., Yang, Y., Niu, P., Meng, G., Cheng, W., Xu, J., Duan, J., Wang, Z., Yu, X., Feng, X., Zhou, J., & Pan, J. (2021). A novel full-human CD22-CAR T cell therapy with potent activity against CD22 low B-ALL. Blood Cancer Journal, 11(4), 1–6. https://doi.org/10.1038/s41408-021-00465-9 Cite
Full Article
Bookmark

No account yet? Register

0
Share

Atractylenolide I Enhances Responsiveness to Immune Checkpoint Blockade Therapy by Activating Tumor Antigen Presentation

In syngeneic mouse colorectal cancer (CRC) models and human patient-derived CRC organoid models, atractylenolide I treatment promoted the cytotoxicity of CD8+ T cells and thus profoundly enhanced the efficacy of immune checkpoint blockade therapy.
[Journal of Clinical Investigation]
Xu, H., Jeught, K. V. der, Zhou, Z., Zhang, L., Yu, T., Sun, Y., Li, Y., Wan, C., So, K., Liu, D., Frieden, M., Fang, Y., Mosley, A. L., He, X., Zhang, X., Sandusky, G. E., Liu, Y., Meroueh, S. O., Zhang, C., … Lu, X. (2021). Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation. The Journal of Clinical Investigation. https://doi.org/10.1172/JCI146832 Cite
AbstractFull ArticleGraphical Abstract
Bookmark

No account yet? Register

0
Share

Genetic Manipulation and Immortalized Culture of Ex Vivo Primary Human Germinal Center B Cells

Researchers describe a detailed protocol for the purification and ex vivo expansion of primary, nonmalignant human germinal center B cells.
[Nature Protocols]
Caeser, R., Gao, J., Di Re, M., Gong, C., & Hodson, D. J. (2021). Genetic manipulation and immortalized culture of ex vivo primary human germinal center B cells. Nature Protocols, 1–21. https://doi.org/10.1038/s41596-021-00506-4 Cite
Abstract
Bookmark

No account yet? Register

0
Share

Human Anogenital Monocyte-Derived Dendritic Cells and langerin+cDC2 Are Major HIV Target Cells

Scientsts showed that HIV could penetrate the epithelial surface to interact with sub-epithelial resident mononuclear phagocytes in anogenital explants and defined the full array of subsets that were present in the human anogenital and colorectal tissues that HIV may encounter during sexual transmission.
[Nature Communications]
Rhodes, J. W., Botting, R. A., Bertram, K. M., Vine, E. E., Rana, H., Baharlou, H., Vegh, P., O’Neil, T. R., Ashhurst, A. S., Fletcher, J., Parnell, G. P., Graham, J. D., Nasr, N., Lim, J. J. K., Barnouti, L., Haertsch, P., Gosselink, M. P., Di Re, A., Reza, F., … Harman, A. N. (2021). Human anogenital monocyte-derived dendritic cells and langerin+cDC2 are major HIV target cells. Nature Communications, 12(1), 2147. https://doi.org/10.1038/s41467-021-22375-x Cite
Full Article
Bookmark

No account yet? Register

0
Share

Atlas of Breast Cancer Infiltrated B-Lymphocytes Revealed by Paired Single-Cell RNA-Sequencing and Antigen Receptor Profiling

Researchers combined single-cell RNA-sequencing and antigen receptor lineage analysis to characterize a large number of triple-negative breast cancer infiltrated immune cells and report a comprehensive atlas of tumor-infiltrated B-lymphocytes.
[Nature Communications]
Hu, Q., Hong, Y., Qi, P., Lu, G., Mai, X., Xu, S., He, X., Guo, Y., Gao, L., Jing, Z., Wang, J., Cai, T., & Zhang, Y. (2021). Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling. Nature Communications, 12(1), 2186. https://doi.org/10.1038/s41467-021-22300-2 Cite
Full Article
Bookmark

No account yet? Register

0
Share

Eotaxin-1/CCL11 Is Involved in Cell Migration in Rheumatoid Arthritis

The authors investigated the expression and function of Eotaxin-1 (CCL11) in rheumatoid arthritis fibroblast-like synoviocytes.
[Scientific Reports]
Wakabayashi, K., Isozaki, T., Tsubokura, Y., Fukuse, S., & Kasama, T. (2021). Eotaxin-1/CCL11 is involved in cell migration in rheumatoid arthritis. Scientific Reports, 11(1), 7937. https://doi.org/10.1038/s41598-021-87199-7 Cite
Full Article
Bookmark

No account yet? Register

0
Share

Lipid Nanoparticle Encapsulated Nucleoside-Modified mRNA Vaccines Elicit Polyfunctional HIV-1 Antibodies Comparable to Proteins in Nonhuman Primates

Researchers showed that mRNA-LNP immunization compared to protein immunization elicits either the same or superior magnitude and breadth of HIV-1 Env-specific polyfunctional antibodies.
[npj Vaccines]
Saunders, K. O., Pardi, N., Parks, R., Santra, S., Mu, Z., Sutherland, L., Scearce, R., Barr, M., Eaton, A., Hernandez, G., Goodman, D., Hogan, M. J., Tombacz, I., Gordon, D. N., Rountree, R. W., Wang, Y., Lewis, M. G., Pierson, T. C., Barbosa, C., … Haynes, B. F. (2021). Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates. Npj Vaccines, 6(1), 1–14. https://doi.org/10.1038/s41541-021-00307-6 Cite
Full Article
Bookmark

No account yet? Register

0
Share
Share